Codiak BioSciences, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 47 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-11-13: Reporting owner Howze Yalonda; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-11-13: Reporting owner Haddock Jason; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-10-15: Reporting owner Sorensen Benny; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2020-10-15: Reporting owner Sorensen Benny; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-11-13 | Howze Yalonda Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,576 41,576 owned after | $8.75 exercise price | 2020-11-17 | |
| 2020-11-13 | Haddock Jason Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,996 7,996 owned after | $8.75 exercise price | 2020-11-17 | |
| 2020-10-15 holding as of filing | Sorensen Benny Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.29 exercise price | 2020-10-15 | ||
| 2020-10-15 holding as of filing | Sorensen Benny Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.17 exercise price | 2020-10-15 | ||
| 2020-10-15 holding as of filing | Sorensen Benny Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.25 exercise price | 2020-10-15 | ||
| 2020-10-14 holding as of filing | Verma Ajay Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.25 exercise price | 2020-10-14 | ||
| 2020-10-14 holding as of filing | Verma Ajay Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.25 exercise price | 2020-10-14 | ||
| 2020-10-14 holding as of filing | Howze Yalonda Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.33 exercise price | 2020-10-14 | ||
| 2020-10-13 | GILLIS STEVEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $15.00 exercise price | 2020-10-15 | |
| 2020-10-13 | Haddock Jason Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $15.00 exercise price | 2020-10-15 | |
| 2020-10-13 | Bernstein Karen Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $15.00 exercise price | 2020-10-15 | |
| 2020-10-13 | LANDER ERIC S Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $15.00 exercise price | 2020-10-15 | |
| 2020-10-13 | Morrison Briggs Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $15.00 exercise price | 2020-10-15 | |
| 2020-10-13 | MELAS KYRIAZI THEO Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $15.00 exercise price | 2020-10-15 | |
| 2020-10-13 | COONEY CHARLES L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $15.00 exercise price | 2020-10-15 | |
| 2020-10-13 holding as of filing | Konstantinov Konstantin Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.29 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Konstantinov Konstantin Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.17 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Konstantinov Konstantin Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.25 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Konstantinov Konstantin Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.25 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Bernstein Karen Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.25 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Haddock Jason Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $19.47 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Bain Linda Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.29 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Bain Linda Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.29 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Bain Linda Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.17 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Bain Linda Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.25 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Bain Linda Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.25 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | WILLIAMS DOUGLAS E Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.29 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | WILLIAMS DOUGLAS E Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.29 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | WILLIAMS DOUGLAS E Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.29 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | WILLIAMS DOUGLAS E Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.17 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | WILLIAMS DOUGLAS E Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.25 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | COONEY CHARLES L Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.29 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | COONEY CHARLES L Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.17 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | LANDER ERIC S Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.29 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | LANDER ERIC S Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.17 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | GILLIS STEVEN Director | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $3.29 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | GILLIS STEVEN Director | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $10.17 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Barna Nicole Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.17 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Barna Nicole Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.25 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Barna Nicole Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.25 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Barna Nicole Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.25 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Brudnick Richard Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.17 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Brudnick Richard Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.17 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | Morrison Briggs Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.17 exercise price | 2020-10-13 | ||
| 2020-10-13 holding as of filing | MELAS KYRIAZI THEO Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.25 exercise price | 2020-10-13 | ||
| 2020-08-26 | Haddock Jason Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +31,981 31,981 owned after | $19.47 exercise price | 2020-10-15 | |
| 2020-07-02 | Howze Yalonda Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +166,304 166,304 owned after | $15.33 exercise price | 2020-11-17 |